home / stock / pypd / pypd quote
Last: | $4 |
---|---|
Change Percent: | 0.25% |
Open: | $3.99 |
Close: | $4 |
High: | $4.11 |
Low: | $3.99 |
Volume: | 3,323 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4 | $3.99 | $4 | $4.11 | $3.99 | 3,323 | 07-05-2024 |
$4 | $4 | $4 | $4.01 | $3.99 | 1,086 | 07-04-2024 |
$4 | $4 | $4 | $4.01 | $3.99 | 1,086 | 07-03-2024 |
$4 | $3.98 | $4 | $4.02 | $3.98 | 2,235 | 07-02-2024 |
$4.24 | $4.49 | $4.24 | $4.49 | $4.2 | 3,624 | 07-01-2024 |
$4.3 | $4.25 | $4.3 | $4.4 | $4.125 | 15,640 | 06-28-2024 |
$4.2 | $4.17 | $4.2 | $4.2 | $3.9 | 1,865 | 06-27-2024 |
$4.0786 | $4.09 | $4.0786 | $4.09 | $4.0786 | 864 | 06-26-2024 |
$3.8829 | $4 | $3.8829 | $4 | $3.8829 | 829 | 06-25-2024 |
$3.98 | $4 | $3.98 | $4 | $3.85 | 2,976 | 06-24-2024 |
$4.26 | $4.26 | $4.26 | $4.26 | $4.26 | 506 | 06-21-2024 |
$4 | $4.225 | $4 | $4.25 | $3.75 | 60,069 | 06-20-2024 |
$4.11 | $4.2 | $4.11 | $4.4255 | $4.06 | 22,247 | 06-19-2024 |
$4.11 | $4.2 | $4.11 | $4.4255 | $4.06 | 22,247 | 06-18-2024 |
$4.185 | $4.36 | $4.185 | $4.37 | $4.1 | 4,185 | 06-17-2024 |
$4.24 | $4.2403 | $4.24 | $4.2403 | $4.24 | 779 | 06-14-2024 |
$4.3 | $4.3 | $4.3 | $4.4 | $4.3 | 1,607 | 06-13-2024 |
$4.2377 | $0 | $4.2377 | $0 | $0 | 16 | 06-12-2024 |
$4.2377 | $0 | $4.2377 | $0 | $0 | 117 | 06-11-2024 |
$4.2377 | $4.49 | $4.2377 | $4.49 | $4.2377 | 710 | 06-10-2024 |
News, Short Squeeze, Breakout and More Instantly...
After a Reduction in Surgical Site Infection (SSI) Rates During COVID, Rates are Now Increasing, Signaling a Return to Pre-COVID Levels Known Procedure and Patient Risk-Factors Significantly Increase the Risk of SSIs and Impact Payer Costs Approximately 250 Patients of a Planned...
Submitted Revised Protocol for SHIELD II Phase 3 Trial to FDA to Evaluate D-PLEX 100 for Prevention of Abdominal Colorectal Surgical Site Infections ; Recruitment Expected to Re sume Imminently Received Advice from the Swedish Medical Prod...
PETACH TIKVA, Israel, April 26, 2023 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its first quarter 2023 financial results...